Access cutting-edge ards treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access ards specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ards treatment provided free
It is hypothesized that instillation of Liothyronine Sodium (T3) into the airspace will be safe, well tolerated, and will increase alveolar fluid clearance and decrease inflammation in patients with ARDS, reflected in improved oxygenation index (OI) and oxygenation saturation index (OSI).
Sponsor: University of Minnesota
Check if you qualify for this ards clinical trial in Minneapolis, MN
If you're searching for ards treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ards specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.